Atrial fibrillation catheter ablation in females: same hardware, different findings

References

• Wazni OM, Marrouche NF, Martin DO et al. Radiofrequency ablation vs antiarrhythmic as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA293, 264–240 (2005).
   Google Scholar
• Camm AJ, Kirchhof P, Lip GY. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur. Heart J.31(19), 2369–2429 (2010).
   PubMed Web of Science ®Google Scholar
• Patel D, Mohanty P, Di Biase L et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm7, 167–172 (2010).
   PubMed Web of Science ®Google Scholar
• Feinberg WM, Blackshear JL, Laupacis A et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch. Intern. Med.155, 469–473 (1995).
   PubMed Web of Science ®Google Scholar
• Larsen J, Kadish A. Effects of gender on cardiac arrhythmias. J. Cardiovascular. Electrophysiol.9, 655–644 (1998).
   Google Scholar
• Humphries KH, Kerr CR, Connolly S et al. New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation103, 2365–2370 (2001).
   PubMed Web of Science ®Google Scholar
• Paquette M, Roy D, Talajic M et al. Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Am. J. Cardiol.86, 764–768 (2000).
   PubMed Web of Science ®Google Scholar
• Friberg J, Scharling H, Gadsboll N et al. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am. J. Cardiol.94, 889–894 (2004).
   PubMed Web of Science ®Google Scholar
• Dagres N, Nieuwlaat R, Vardas PE et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J. Am. Coll. Cardiol.49, 572–577 (2007).
   PubMed Web of Science ®Google Scholar
• Fang MC, Singer DE, Chang Y et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the Anticoagulation and Risk Factors In Atrial fibrillation (ATRIA) study. Circulation112, 1687–1691 (2005).
   PubMed Web of Science ®Google Scholar
• Rienstra M, Van Veldhuisen DJ, Hagens VE et al. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. J. Am. Coll. Cardiol.46, 1298–1306 (2005).
   PubMed Web of Science ®Google Scholar
• Van Gelder IC, Hagens VE, Bosker HA et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N. Engl. J. Med.23, 1834–1840 (2002).
   Google Scholar
• Wolbrette DL. Risk of proarrhythmia with class III antiarrhythmia agents: sex based differences and other issues. Am. J. Cardiol.91, D39–D44 (2003).
   PubMed Web of Science ®Google Scholar
• Kurokawa J, Tamagawa M, Harada N et al. Acute effects of estrogen on the guinea pig and human IKr channels and drug-induced prolongation of cardiac repolarization. J. Physiol.12, 2961–2973 (2008).
   Google Scholar
• Rodriguez I, Kilborn MJ, Liu XK et al. Drug-induced QT prolongation in women during the menstrual cycle. JAMA285, 1322–1326 (2001).
   PubMed Web of Science ®Google Scholar
• Dagres N, Clague J, Breithardt G et al. Significant gender-related differences in radiofrequency catheter ablation therapy. J. Am. Coll. Cardiol.42, 1103–1107 (2003).
   PubMed Web of Science ®Google Scholar
• Fuster V, Rydén LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation7, 257–354 (2006).
   Google Scholar
• Oral H, Pappone C, Chugh A et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N. Engl. J. Med.354, 934–941 (2006).
   PubMed Web of Science ®Google Scholar
• Haïssaguerre M, Hocini M, Sanders P et al. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J. Cardiovasc. Electrophysiol.16, 1138–1147 (2005).
   PubMed Web of Science ®Google Scholar
• Natale A, Raviele A, Arentz T et al. Venice Chart international consensus document on atrial fibrillation ablation. J. Cardiovasc. Electrophysiol.18, 560–580 (2007).
   PubMed Web of Science ®Google Scholar
• Roten L, Rimoldi S, Schwick N et al. Gender differences in patients referred for atrial fibrillation management to a tertiary center. PACE32, 622–626 (2009).
   Google Scholar
• Forleo G, Tondo C, Luca L et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace9, 613–620 (2007).
   PubMed Web of Science ®Google Scholar
• Lee SH, Tai CT, Hseih MH et al. Predictors of nonpulmonary vein ectopic beats initiating paroxysmal atrial fibrillation: implications for catheter ablation. J. Am. Coll. Cardiol.46, 1056–1059 (2005).
   Google Scholar
• Sauer WH, Alonso C, McKernan M et al. Female gender is associated with the presence of nonpulmonary vein triggers of atrial fibrillation (abstr). Circulation108(Suppl. 5), 617 (2003).
   Google Scholar
• Hughes P, Scott C, Bodenham A. Ultrasonography of the femoral vessels on the groin: implications for vascular access. Anaesthesia55, 1198–1202 (2000).
   Google Scholar
• Spragg DD, Dalal D, Cheema A et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors. J. Cardiovasc. Electrophysiol.19, 627–631 (2008).
   PubMed Web of Science ®Google Scholar